Title |
Current treatment options for the management of esophageal cancer
|
---|---|
Published in |
Cancer Management and Research, November 2012
|
DOI | 10.2147/cmar.s27593 |
Pubmed ID | |
Authors |
Mark R Mawhinney, Robert E Glasgow |
Abstract |
In recent years, esophageal cancer characteristics and management options have evolved significantly. There has been a sharp increase in the frequency of esophageal adenocarcinoma and a decline in the frequency of squamous cell carcinoma. A more comprehensive understanding of prognostic factors influencing outcome has also been developed. This has led to more management options for esophageal cancer at all stages than ever before. A multidisciplinary, team approach to management in a high volume center is the preferred approach. Each patient should be individually assessed based on type of cancer, local or regional involvement, and his or her own functional status to determine an appropriate treatment regimen. This review will discuss management of esophageal cancer relative to disease progression and patient functional status. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
India | 1 | 2% |
Egypt | 1 | 2% |
Unknown | 43 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 17% |
Researcher | 8 | 17% |
Student > Bachelor | 7 | 15% |
Student > Ph. D. Student | 5 | 11% |
Other | 3 | 7% |
Other | 8 | 17% |
Unknown | 7 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 41% |
Nursing and Health Professions | 6 | 13% |
Agricultural and Biological Sciences | 5 | 11% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Other | 4 | 9% |
Unknown | 9 | 20% |